Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Busy address KBO
17 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
HEMOTECH BELUX from Koekelare, company number BE0474412845, closed financial year 2025 with a result of € 23,980 after tax. For that financial year HEMOTECH BELUX recorded a gross margin of € 1.5 million and equity of € 859,416. Compared with financial year 2024, the result moved from € 118,944 to € 23,980. The company is profitable. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on July 9, 2026.
€ 859,416
▲ 3% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 23,980
▼ 80% vs 2024
Profit after tax over the fiscal year.
€ 0
▼ 100% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € -41,478.
People and assets in 2025
10.6
▼ 0.8 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 1.1 million
▲ 9% vs 2024
€ 104,400 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 35,206
▼ 20% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 630,000
Loans from banks and other lenders, long and short.
€ 1.1 million
▼ 15% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 278,922
▲ 57% vs 2024
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 574,371 | € 828,176 | € 1,420,533 | € 1,468,612 | ▲ 3% |
| Profit after taxes | € -285,130 | € -184,402 | € 118,944 | € 23,980 | ▼ 80% |
| Equity | € 500,894 | € 716,493 | € 835,437 | € 859,416 | ▲ 3% |
| Total debts | € 2,377,222 | € 2,543,761 | € 3,484,963 | € 4,098,381 | ▲ 18% |
| Cash | € 28,384 | € 470 | € 170 | € 0 | ▼ 100% |
| Retained profit | € -319,566 | € -184,402 | € -65,458 | € -41,478 | ▲ € 23,980 |
| Bank debt | € 1,125,000 | € 1,125,000 | € 630,000 | € 630,000 | |
| Balance sheet total | € 2,915,712 | € 3,260,253 | € 4,320,400 | € 4,957,797 | ▲ 15% |
| Employees (FTE) | 7.8 | 9.2 | 11.4 | 10.6 | ▼ 0.8 |
Key figures of HEMOTECH BELUX, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to HEMOTECH BELUX?
What happened at HEMOTECH BELUX in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 23,980 (▼ 80% vs 2024). Source: NBB ↗
- POLLET MEDICAL GROUP NV became a director. NBB
- Smardix Besloten Vennootschap became a director. NBB
- Linus BV became a director. NBB
- New establishment in Mechelen. KBO
- VDW Consults BV became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 285,130 loss in 2022 to € 23,980 profit in 2025.
Paid € 92,854 in corporate taxes since 2022.
Best year ever: 2024, with € 118,944 profit.
On average € 138,500 of value added per employee in 2025.
Management
The stake of POLLET MEDICAL GROUP comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
HEMOTECH BELUXBehind HEMOTECH BELUX are VDW Consults BV, POLLET MEDICAL GROUP NV, Smardix Besloten Vennootschap and Linus BV. The shares are held by POLLET MEDICAL GROUP (100%).
Directors
According to the 2025 annual accounts
Director · represented by Mats Vandeweeghde
since 2021
Voorzitter van het Bestuursorgaan · represented by Sofie POLLET
Also active at: TERBASSENWEI, STERIMA, Sterima Medical & Logistic Services Liège, Integrated Service Solutions Hospitals
since 2024
Director · represented by Taillieu Dimitri
Also active at: TERBASSENWEI, STERIMA, EURAQUA-EUROPE, UNIMID, PPG Belgium, ALTRANS, POLLET GROUP, MICRON +14 more
since 2024
since 2022
Shareholders
100%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Brouwerijstraat 14
8680 Koekelare
Blarenberglaan 21
2800 Mechelen
Active since 1 June 2022
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 17 companies are registered at this address.
All companies at this address →TERBASSENWEI same network
€ 3 million gross margin · 2025
UNIMID same network
€ -249,093 gross margin · 2025
PPG Belgium same network
€ 33.4 million revenue · 2025
ALTRANS same network
€ 824,938 gross margin · 2025
POLLET GROUP same network
€ 7.8 million revenue · 2025
+12 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0474.412.845
- VAT number
- BE 0474.412.845
- Registered office
- Brouwerijstraat 14, 8680 Koekelare
- Names & denominations
- HEMOTECH BELUX
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 26 March 2001
- Peppol
- Active · Active since 1 Jan 2001
- Activities · NACE
Groothandel in farmaceutische en medische artikelen
Groothandel in farmaceutische producten
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Overige adviesbureaus op het gebied van bedrijfsvoering en beheer
Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering